March 13, 2015

New relationship for UNM Cancer Center brings scientific, economic possibilities
Albuquerque Business First – March 12

The University of New Mexico Cancer Center has joined the Oncology Research Information Exchange Network (ORIEN), one of the largest precision medicine research consortiums in the country. Originally a partnership between the Moffitt Cancer Center in Florida and the Ohio State University Comprehensive Cancer Center, the consortium now consists of six centers nationally, including cancer centers attached to the University of Virginia and University of Colorado, and seeks to share funding and data to advance precision medicine initiatives based on genomic sequencing data in cancer patients.

Gene variant increases risk and severity of nerve disorder linked to vincristine
Oncology Nurse Advisor – March 12
”It is not clear that vincristine can be removed from the treatment options for a child with CEP72 variants, although this study suggests that the resulting increase in leukemia cellular sensitivity makes vincristine dose reductions possible without compromising antileukemic effect,” said Howard L. McLeod, PharmD, of the Moffitt Cancer Center in Tampa, Florida in an accompanying editorial. 

Asparaginase in Acute Lymphoblastic Leukemia
OncLive – March 10
Panelists: Dan Douer, MD, MSK; Richard M. Harris, MD, Cedars Sinai; Jeffrey Lancet, MD, Moffitt; Mark R. Litzow, MD, Mayo Clinic; Leonard S. Sender, MD, UC Irvine; Raoul Tibes, MD, PhD, Mayo Clinic 

Study Provides 'Strong Evidence' Backing Warfarin Initiation PGx Testing; Adoption Impact Unclear
GenomeWeb – March 10
"The large sample size and preplanned inclusion of genotype make this an important study. This will be enough to drive some programs to start or restart the use of CYP2C9/VKORC1 [testing] in their practices," Howard McLeod, medical director of the Personalized Medicine Institute at the Moffitt Cancer Center, told GenomeWeb.

Dianne Knight, MD, Awarded Fellow Status from the American Academy of Hospice and Palliative Medicine
The ASCO Post – March 10
Dianne Knight, MD, Physician in the Supportive Care Medicine Department at Moffitt Cancer Center, has been honored with the designation of Fellow of the American Academy of Hospice and Palliative Medicine.

Inherited gene variant increases neuropathy risk in children with ALL
HemOnc Today – March 9
Despite the findings, it remains unclear whether vincristine can be removed from treatment options for children withCEP72 variants, Howard L. McLeod, PharmD, senior member of the DeBartolo Family Personalized Medicine Institute at Moffitt Cancer Center, wrote in an accompanying editorial.

BUSINESS NEWS: Achievers
The Tampa Tribune – March 8
Diane Knight, a physician with the Supportive Care Medicine Department at Moffitt Cancer Center, has been honored with the designation of fellow of the American Academy of Hospice and Palliative Medicine.

MEN'S HEALTH FORUM TODAY AT USF
Bay News 9 – March 7
Boxing, back massages and even a Buccaneer or two today at Moffitt Cancer Center’s Men’s Health Forum.

New Cancer Technology
Bay News 9 – March 6
In Depth this Friday on some groundbreaking new technology being used right here in the Bay area that is changing the face of cancer treatment. Doctors at Moffitt Cancer Center in Tampa have two new systems they say can pinpoint certain types of lung cancer detecting it earlier than ever before.

Dr. Komrokji on MDS Risk Factors and Preventative Measures
OncLive – March 6
Rami S. Komrokji, MD, clinical director, Hematologic Malignancies, Moffitt Cancer Center, discusses the risk factors of developing myelodysplastic syndromes (MDS) and any preventative measures.

CytomX Creates Advisory Boards to Support Immunotherapy Research
Immuno-Oncology News – March 5
The new Immunotherapy Advisory Board will include assistant professor of medicine at the Stanford University Medical Center, Holbrook Kohrt, MD, PhD, as well as professor of medicine and hematology/oncology, at the University of California, Los Angeles, Antoni Ribas, MD, PhD, and director of the Donald A. Adam Comprehensive Melanoma Research Center – Moffitt Cancer Center, Jeffrey Weber, MD, PhD.

###

Please note we cannot guarantee the accuracy or availability of links. The stories belong to the respective publishers, and links may expire. Some news sites require you to register and select a password in order to retrieve articles, but most usually do not charge a fee to retrieve these news stories.